-- 根據FactSet調查的分析師報告，Ultragenyx Pharmaceutical (RARE) 的平均評級為“買入”，平均目標價為53.40美元。 （報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們：https://www..com/contact-us）
Related Articles
Australia
MSC Industrial Direct Shares Rise After KeyBanc Upgrade
MSC Industrial Direct (MSM) shares were up 5.4% in Monday afternoon trading after KeyBanc upgraded its rating on the company's stock to overweight from sector weight and set a $117 price target.Trading volume exceeded 843,000 shares, compared with a daily average of nearly 646,000.Price: $103.07, Change: $+5.24, Percent Change: +5.36%
$MSM
Australia
CrowdStrike Shares Rise After Mizuho Upgrade
CrowdStrike (CRWD) shares were up about 1.6% in Monday trading after Mizuho upgraded the stock to outperform from neutral and boosted its price target to $520 from $490.Trading volume stood at more than 1.4 million shares, compared with a daily average of about 4.2 million.Price: $455.31, Change: $+7.18, Percent Change: +1.60%
$CRWD
Australia
Citigroup Lowers Domino's Pizza Price Target to $3650 From $425, Maintains Neutral Rating
Domino's Pizza (DPZ) has an average rating of overweight and mean price target of $459.09, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $335.23, Change: $-32.96, Percent Change: -8.95%
$DPZ